Kim, P. S., Kwilas, A. R., Xu, W., Alter, S., Jeng, E. K., Wong, H. C., . . . Hodge, J. W. (2016). IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas. Oncotarget.
Citação norma ChicagoKim, Peter S., Anna R. Kwilas, Wenxin Xu, Sarah Alter, Emily K. Jeng, Hing C. Wong, Jeffrey Schlom, and James W. Hodge. "IL-15 Superagonist/IL-15RαSushi-Fc Fusion Complex (IL-15SA/IL-15RαSu-Fc; ALT-803) Markedly Enhances Specific Subpopulations of NK and Memory CD8+ T Cells, and Mediates Potent Anti-tumor Activity against Murine Breast and Colon Carcinomas." Oncotarget 2016.
Citação norma MLAKim, Peter S., et al. "IL-15 Superagonist/IL-15RαSushi-Fc Fusion Complex (IL-15SA/IL-15RαSu-Fc; ALT-803) Markedly Enhances Specific Subpopulations of NK and Memory CD8+ T Cells, and Mediates Potent Anti-tumor Activity against Murine Breast and Colon Carcinomas." Oncotarget 2016.